(Health-NewsWire.Net, November 22, 2016 ) The Multiple Myeloma (MM) market is currently dominated by Velcade and Revlimid, and the market is set to undergo substantial growth between 2013 and 2023. The main drivers of growth will be the launch of monoclonal antibodies (mAbs) Empliciti and daratumumab,...
(Health-NewsWire.Net, November 22, 2016 ) Physical sterilizers to conduct steam sterilization dominate the sterilization equipment market.Chemical sterilizers using low-temperature sterilization technology have consistently gained acceptance. Among all chemical sterilizers, hydrogen peroxide sterilizers...
(Health-NewsWire.Net, November 22, 2016 ) Central vascular devices, particularly catheters, have been a mainstay of modern medicine for the last 40 years. These devices are intended for patients with both acute and chronic diseases such as systemic infections, which require catheters that are able...
(Health-NewsWire.Net, November 22, 2016 ) Rheumatoid Arthritis (RA) is the commonest autoimmune disease in humans. The disease is prevalent in all ethnic groups, affecting approximately 1.0% of the world population. Presently there is a huge presence of unmet patient needs for both the treatment...
(Health-NewsWire.Net, November 22, 2016 ) Prompt hemostasis, effective incision closure, tissue and vessel sealing, and post-operative adhesion prevention have been paramount concerns for surgeons for decades. As medical technology advances, the surgeon's toolbox expands to include more effective...
(Health-NewsWire.Net, November 22, 2016 ) Publisher's, 'Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2016', provides an overview of the Leishmaniasis (Kala-Azar) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Leishmaniasis (Kala-Azar),...
(Health-NewsWire.Net, November 22, 2016 ) " Low Back Pain-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Low Back Pain. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery,...
(Health-NewsWire.Net, November 22, 2016 ) Publisher's, "Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists. The Publisher's...
(Health-NewsWire.Net, November 22, 2016 ) " Renal Osteodystrophy-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Renal Osteodystrophy. The DelveInsight'sReport covers the product profiles in various stages of development...
(Health-NewsWire.Net, November 22, 2016 ) " Primary Biliary Cirrhosis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Primary Biliary Cirrhosis. The DelveInsight'sReport covers the product profiles in various stages of...
(Health-NewsWire.Net, November 21, 2016 ) Publisher's, "VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the VCAM-1 (vascular cell adhesion molecule-1) gene...
(Health-NewsWire.Net, November 21, 2016 ) Publisher's, "Sphingosine 1-Phosphate Type 1 (S1P-1) Receptor Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Sphingosine 1-Phosphate Type 1 (S1P-1) Receptor Agonists....
(Health-NewsWire.Net, November 21, 2016 ) "Spasticity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Spasticity...
(Health-NewsWire.Net, November 21, 2016 ) Publisher's, "Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Rho Kinase (Rho-Associated Coiled-Coil...
(Health-NewsWire.Net, November 21, 2016 ) "Pruritus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Pruritus...
|